Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (211-220 of 333) with videos related to

Pageof 34
Sort By:
Pediatrics|October 21, 2009
Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 yearR Scott Watson, Gilles Clermont, John P Kinsella, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosisMarcus Koch, Jop Mostert, Eva M Strijbis, et al.
Genetic Epidemiology|October 21, 2021
Mendelian randomization in the multivariate general linear model frameworkPhillip H Allman, Inmaculada Aban, Dustin M Long, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Effects of exercise on sleep spindles in Parkinson's diseaseAdeel Ali Memon, Corina Catiul, Zachary Irwin, et al.
Plos One|February 23, 2011
Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patientsBianca Weinstock-Guttman, Robert Zivadinov, Gary Cutter, et al.
Academic Radiology|September 14, 2024
Improving the Assessment of Axonal Injury in Early Multiple SclerosisAhmad A Toubasi, Gary Cutter, Caroline Gheen, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 10, 2024
Improving the Detection of Myelin Integrity in Multiple Sclerosis Using Selective Inversion Recovery for MRI With Quantitative Magnetization TransferAhmad A Toubasi, Dhairya A Lakhani, Gary Cutter, et al.
BMJ Open|December 4, 2012
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyDouglas S Goodin, George C Ebers, Gary Cutter, et al.
Archives of Neurology|September 10, 2008
Reproducibility of optical coherence tomography in multiple sclerosisDeanna Cettomai, Mathew Pulicken, Eliza Gordon-Lipkin, et al.
Lancet (London, England)|February 11, 2014
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trialAndrew S C Rice, Robert H Dworkin, Tom D McCarthy, et al.
Pageof 34

Showing results (211-220 of 333) with videos related to

Sort By:
Pageof 34
Pediatrics|October 21, 2009
Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 yearR Scott Watson, Gilles Clermont, John P Kinsella, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosisMarcus Koch, Jop Mostert, Eva M Strijbis, et al.
Genetic Epidemiology|October 21, 2021
Mendelian randomization in the multivariate general linear model frameworkPhillip H Allman, Inmaculada Aban, Dustin M Long, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Effects of exercise on sleep spindles in Parkinson's diseaseAdeel Ali Memon, Corina Catiul, Zachary Irwin, et al.
Plos One|February 23, 2011
Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patientsBianca Weinstock-Guttman, Robert Zivadinov, Gary Cutter, et al.
Academic Radiology|September 14, 2024
Improving the Assessment of Axonal Injury in Early Multiple SclerosisAhmad A Toubasi, Gary Cutter, Caroline Gheen, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 10, 2024
Improving the Detection of Myelin Integrity in Multiple Sclerosis Using Selective Inversion Recovery for MRI With Quantitative Magnetization TransferAhmad A Toubasi, Dhairya A Lakhani, Gary Cutter, et al.
BMJ Open|December 4, 2012
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyDouglas S Goodin, George C Ebers, Gary Cutter, et al.
Archives of Neurology|September 10, 2008
Reproducibility of optical coherence tomography in multiple sclerosisDeanna Cettomai, Mathew Pulicken, Eliza Gordon-Lipkin, et al.
Lancet (London, England)|February 11, 2014
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trialAndrew S C Rice, Robert H Dworkin, Tom D McCarthy, et al.
Pageof 34